Published in

American Medical Association, JAMA Internal Medicine, 2022

DOI: 10.1001/jamainternmed.2022.4226

Links

Tools

Export citation

Search in Google Scholar

Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016

This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

This cohort study used the Drugs@FDA database to identify new drugs approved by the US Food and Drug Administration (FDA) and assess fulfillment of postmarket commitments and requirements.